Understanding Repeat Positive HIV Testing in South Africa Under Changing Treatment Guidelines

被引：0
作者：
Maria F. Nardell
Bethany Hedt-Gauthier
Valerie A. Earnshaw
Laura M. Bogart
Janan J. Dietrich
Ingrid Courtney
Gugulethu Tshabalala
Jacob Bor
Catherine Orrell
Glenda Gray
David R. Bangsberg
Ingrid T. Katz
机构：
[1] Division of Global Health Equity,Department of Medicine
[2] Brigham and Women’s Hospital,Department of Global Health and Social Medicine
[3] Harvard Medical School,Department of Human Development and Family Sciences
[4] Brigham and Women’s Hospital,Perinatal HIV Research Unit, Faculty of Health Sciences
[5] Harvard Medical School,Department of Global Health
[6] Massachusetts General Hospital Center for Global Health,Office of the President
[7] University of Delaware,undefined
[8] RAND Corporation,undefined
[9] University of Witwatersrand,undefined
[10] Health Systems Research Unit,undefined
[11] South African Medical Research Council,undefined
[12] Desmond Tutu Health Foundation,undefined
[13] University of Cape Town Medical School,undefined
[14] Boston University School of Public Health,undefined
[15] South African Medical Research Council,undefined
[16] Oregon Health & Science University-Portland State University School of Public Health,undefined
[17] Harvard Global Health Institute,undefined
来源：
AIDS and Behavior | 2022年 / 26卷
关键词：
Repeat positive testing; Retesting; South Africa; Antiretroviral treatment initiation; Coping;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Some people with HIV (PWH) test positive multiple times without initiating antiretroviral therapy (ART). We surveyed 496 ART-eligible PWH following routine HIV testing at three clinics in Soweto and Gugulethu, South Africa in 2014–2015. Among repeat positive testers (RPTs) in this cohort, we compared rates of treatment initiation by prior treatment eligibility and assessed psychosocial predictors of treatment initiation in logistic regression models. RPTs represented 33.8% of PWH in this cohort. Less than half of those who reported eligibility for ART on prior testing started treatment upon retesting, in contrast to two thirds of RPTs who were previously ineligible for treatment who started treatment once they learned of their eligibility. Those who reported coping through substance use were more likely to decline treatment versus those not using substances. PWH who test repeatedly represent a vulnerable population at risk for ART non-initiation who may benefit from interventions addressing individualized coping strategies.
引用
收藏
页码：1366 / 1376
页数：10
相关论文
共 227 条
[1]  
Kulkarni S(2017)“Testing, Testing”: Multiple HIV-positive tests among patients initiating antiretroviral therapy in Ethiopia J Int Assoc Provid AIDS Care JIAPAC 16 546-554
[2]  
Tymejczyk O(2018)Monitoring progress towards the first UNAIDS target: understanding the impact of people living with HIV who re-test during HIV-testing campaigns in rural Mozambique J Int AIDS Soc 21 e25095-407
[3]  
Gadisa T(2020)Utility of digitising point of care HIV test results to accurately measure, and improve performance towards, the UNAIDS 90–90–90 targets. Lessells RJ, editor PLoS ONE 15 e0235471-139
[4]  
Fuente-Soro L(2020)Predictors of first-time and repeat HIV testing among HIV-positive individuals in Kenya JAIDS J Acquir Immune Defic Syndr 85 399-689
[5]  
Lopez-Varela E(2010)The ‘“ART”’ of Linkage: Pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa PLoS ONE 5 8-143
[6]  
Augusto O(2009)Loss to care and death before antiretroviral therapy in Durban, South Africa J Acquir Immune Defic Syndr 51 135-2552
[7]  
Jacob N(2014)Attrition through Multiple Stages of Pre-Treatment and ART HIV Care in South Africa Graham SM, editor PLoS ONE 9 e110252-2181
[8]  
Rice B(2014)Continuum in HIV care from entry to ART initiation in rural KwaZulu-Natal South Africa Trop Med Int Health 19 680-993
[9]  
Kalk E(2017)Changing the South African national antiretroviral therapy guidelines: The role of cost modelling Lima VD, editor PLoS ONE 12 e0186557-84
[10]  
De Anda S(2014)Adult antiretroviral therapy guidelines 2014 South Afr J HIV Med 15 121-714
12345678910